CXCR4-targeted liposomal mediated co-delivery of pirfenidone and AMD3100 for the treatment of TGFβ-induced HSC-T6 cells activation

CXCR4-targeted liposomal mediated co-delivery of pirfenidone and AMD3100 for the treatment of TGFβ-induced HSC-T6 cells activation

Aftab Ullah,1 Kaikai Wang,1 Pengkai Wu,1 David Oupicky,1,2 Minjie Sun11State Key Laboratory of Natural Medicines, Department of Pharmaceutics, China Pharmaceutical University, Nanjing 210009, People’s Republic of China; 2Center for Drug Delivery and Nanomedicine, Department of Pharmaceutic...

Full description

Bibliographic Details
Main Authors: Ullah A, Wang K, Wu P, Oupicky D, Sun M
Format: Article
Language:English
Published: Dove Medical Press 2019-04-01
Series:International Journal of Nanomedicine
Subjects:
AMD3100
Pirfenidone
liposome
liver fibrosis
Online Access:https://www.dovepress.com/cxcr4-targeted-liposomal-mediated-co-delivery-of-pirfenidone-and-amd31-peer-reviewed-article-IJN

Internet

https://www.dovepress.com/cxcr4-targeted-liposomal-mediated-co-delivery-of-pirfenidone-and-amd31-peer-reviewed-article-IJN

Similar Items